XML 24 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-based Compensation - Additional Information (Detail)
$ in Millions
6 Months Ended
Jun. 30, 2015
USD ($)
plan
shares
Jun. 30, 2014
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of equity compensation plans | plan 2  
Stock-based awards, shares granted 921,400  
Restricted stock, shares issued 99,027 0
2013 Omnibus incentive plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity awards 5,729,068  
Stock-based awards, shares granted 921,400 1,143,700
2005 Aerie Pharmaceutical stock plan and 2013 omnibus incentive plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation expense | $ $ 31.4  
Compensation cost, weighted average recognition period 2 years 9 months 24 days  
Options outstanding, weighted average remaining contractual life 8 years 3 months 9 days  
Restricted stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation expense | $ $ 2.4  
Restricted stock awards, weighted average remaining contractual term 3 years 3 months 7 days  
Restricted stock, shares issued 99,027  
Restricted stock | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based awards, vesting period 2 years  
Restricted stock | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based awards, vesting period 4 years